1. Department of Pediatric Hematology, Ege University Hospital, Izmir, Turkey;
2. First Department of Pediatrics, University of Athens, Athens, Greece;
3. Universitá di Milano, Ca Granda Foundation Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;
4. Department of Hematology, Pediatric Hospital, Cairo University, Cairo, Egypt;
5. Ospedale Regionale per le Microcitemie, University of Cagliari, Cagliari, Italy;
6. Thalassemia Center, Children's Hospital, Ain Shams University, Cairo, Egypt;
7. Medical Facility, Cukurova University, Adana, Turkey;
8. Department of Woman, Child and of General and Specialist Surgery, I°Policlinico II°Università di Napoli, Naples, Italy;
9. Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey;
10. Department of Pediatrics and Thalassemia Center, Siriraj Hospital, Mahidol University, Bangkok, Thailand;
11. Novartis Pharmaceuticals, East Hanover, NJ;
12. Novartis Pharma AG, Basel, Switzerland; and
13. Department of Hematology, UCL Cancer Institute, University College London, London, United Kingdom